Portfolio (Quarterly)
Guide ↗
Objectivity Squared, LLC
· CIK 0002011113| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | VCSH | VANGUARD SCOTTSDALE FDS | — | 4,975.0 | $398K | 0.24% | NEW | — | $79.93 | -1.3% |
| 42 | NSC | NORFOLK SOUTHN CORP | Industrials | 1,193.0 | $358K | 0.21% | NEW | — | $300.47 | +3.7% |
| 43 | IWM | ISHARES TR | — | 1,339.0 | $324K | 0.19% | NEW | — | $241.95 | +16.8% |
| 44 | IWR | ISHARES TR | — | 3,304.0 | $319K | 0.19% | NEW | — | $96.54 | +8.8% |
| 45 | PYPL | PAYPAL HLDGS INC | Financial Services | 4,455.0 | $299K | 0.18% | NEW | — | $67.06 | -33.8% |
| 46 | T | AT&T INC | Communication Services | 10,455.0 | $295K | 0.18% | NEW | — | $28.24 | -11.7% |
| 47 | PEP | PEPSICO INC | Consumer Defensive | 2,069.0 | $291K | 0.17% | NEW | — | $140.45 | +6.0% |
| 48 | GOOGL | ALPHABET INC | Communication Services | 966.0 | $235K | 0.14% | NEW | — | $243.22 | +59.4% |
| 49 | APH | AMPHENOL CORP NEW | Technology | 1,815.0 | $225K | 0.13% | NEW | — | $123.76 | +0.9% |
| 50 | — | BERKSHIRE HATHAWAY INC DEL | — | 438.0 | $220K | 0.13% | NEW | — | $502.74 | — |
| 51 | EFA | ISHARES TR | — | 2,226.0 | $208K | 0.12% | NEW | — | $93.35 | +11.6% |
| 52 | WMT | WALMART INC | Consumer Defensive | 1,978.0 | $204K | 0.12% | NEW | — | $103.06 | +27.0% |
| 53 | GNW | GENWORTH FINL INC | Financial Services | 19,907.0 | $177K | 0.11% | NEW | — | $8.90 | +3.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Energy
29.0%
Technology
26.6%
Communication Services
16.4%
Industrials
8.1%
Consumer Cyclical
7.9%
Utilities
5.9%
Financial Services
4.0%
Consumer Defensive
1.1%
Healthcare
1.0%